1. Home
  2. SANA vs ADAM Comparison

SANA vs ADAM Comparison

Compare SANA & ADAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

N/A

Current Price

$2.90

Market Cap

793.1M

Sector

Health Care

ML Signal

N/A

ADAM

Adamas Trust Inc.

N/A

Current Price

$7.78

Market Cap

826.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SANA
ADAM
Founded
2018
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
793.1M
826.7M
IPO Year
2021
2003

Fundamental Metrics

Financial Performance
Metric
SANA
ADAM
Price
$2.90
$7.78
Analyst Decision
Strong Buy
Hold
Analyst Count
9
7
Target Price
$8.43
★ $12.13
AVG Volume (30 Days)
★ 3.4M
1.0M
Earning Date
11-05-2026
10-28-2026
Dividend Yield
N/A
★ 13.88%
EPS Growth
17.24
★ 196.49
EPS
N/A
★ 0.87
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$11.19
P/E Ratio
★ N/A
$9.14
Revenue Growth
N/A
N/A
52 Week Low
$2.61
$6.45
52 Week High
$6.55
$10.36

Technical Indicators

Market Signals
Indicator
SANA
ADAM
Relative Strength Index (RSI) 36.78 13.63
Support Level $2.64 $7.09
Resistance Level $3.41 $7.80
Average True Range (ATR) 0.17 0.21
MACD -0.02 -0.12
Stochastic Oscillator 11.77 1.33

Price Performance

Historical Comparison
SANA
ADAM

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

About ADAM Adamas Trust Inc.

Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.

Share on Social Networks: